Pain caused by bone metastasis in endocrine therapy refractory prostate cancer

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 10, 1996, Pages 633-637

  Akakura, Koichiro ^a   Akimoto, Susumu ^a   Shimazaki, Jun ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Bone metastasis; Endocrine therapy refractory state; Pain; Prostate cancer

Indexed keywords

ANALGESIC AGENT; OPIATE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER PAIN; CLINICAL ARTICLE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0029811462     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01221197     Document Type: Article

References (23)

1. Akimoto S, Ohki T, Akakura K, Masai M, Shimazaki J (1994) Chemotherapy for endocrine therapy-refractory prostate cancer. Cancer Chemother Pharmacol 35:18-22
2. Akimoto S, Masai M, Akakura K, Shimazaki J (1995) Tumor marker doubling lime in patients with prostate cancer: determination of prostate-specific antigen and prostatic acid phosphatase doubling time. Eur Urol 27:207-212
3. Bruchovsky N (1993) Androgens and antiandrogens. In: Holland JF, Frei E III, Bast RC Jr, Kufe DW, Morton DJ, Weichselbaum RR (eds) Cancer medicine. Lea & Febiger, Philadelphia, pp 884-896
4. Cherny NI, Portenoy RK (1993) Cancer pain management. Current strategy. Cancer 72:3393-3415
5. Cox DR (1972) Regression models and life tables. J R Statist Soc 34:187-220
6. D'Amico AV, Hanks GE (1993) Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer. Cancer 72:2638-2643
7. Galasko CSB (1982) Mechanisms of lytic and blastic metastatic disease of bone. Clin Orthop 169:20-27
8. Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemother Rep 50:125-136
9. Herr HW, Kornblith AB, Ofman U (1993) A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer 71:1143-1150
10. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:457-481
11. Kuriyama M, Atkimoto S, Akaza H, Arai Y, Usami M, Imai K, Tanaka Y, Yamazaki H, Kawada Y, Koiso K, Yoshida O, Kotake T, Yamanaka H, Machida T, Aso Y, Shimazaki J (1992) Comparison of various assay systems of prostate-specific antigen for standardization. Jpn J Clin Oncol 22:393-399
12. Murphy GP, Natarajan N, Pontes JE, Schmitz RL, Smart CR, Schmidt JD, Mettlin C (1982) The national survery of prostate cancer in the United States by the American College of Surgeons. J Urol 127:928-934
13. Payne R (1993) Pain management in the patient with prostate cancer. Cancer 71:1131-1137
14. Portenoy RK, Miransky J, Thaler HT, Hornung J, Bianchi C, Cibas-Kong I, Feldhamer E, Lewis F, Matamoros I, Sugar MZ, Olivieri AP, Kemeny NE, Foley KM (1992) Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect. Cancer 70:1616-1624
15. Portenoy RK, Kornblith AB, Wong G, Vlamis V, Lepore JM, Loseth DB, Hakes T, Foley KM, Hoskins WJ (1994) Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms. Cancer 74:907-915
16. Schmid H-P, McNeal JE, Stmey TA (1993) Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 71:2031-2040
17. Schmidt JD, Mettlin CJ, Natarajan N, Peace BB, Beart RW Jr, Winchester DP, Murphy GP (1986) Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons. J Urol 136:416-421
18. Silva FC da, Reis E, Costa T, Denis L, the members of Quality of Life Committee of the EORTC Genitourinary Group (1993) Quality of life in patients with prostatic cancer. A feasibility study. Cancer 71:1138-1142
19. Smith JA Jr (1987) New methods of endocrine management of prostatic cancer. J Urol 137:1-10
20. Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, Moinuddin M (1988) Stratification of patients with metastatic prostatic cancer based on extent of disease on initial bone scan. Cancer 61:195-202
21. Surya BV, Provet JA (1989) Manifestation of advanced prostate cancer: prognosis and treatment. J Urol 142:921-928
22. Tong D, Gillick L, Hendrickson FR (1982) The palliation of symptomatic osseous metastases. Final results of the study by the radiation therapy oncology group. Cancer 50:893-899
23. World Health Organization (1990) Cancer pain relief and palliative care: report of a WHO expert committee. World Health Organization, Geneva